Polar Asset Management Partners Inc. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,900 shares of the healthcare conglomerate’s stock, valued at approximately $1,973,000.
Several other large investors also recently added to or reduced their stakes in UNH. Waycross Partners LLC lifted its position in shares of UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares during the period. Full Sail Capital LLC lifted its holdings in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after buying an additional 33 shares during the period. Lmcg Investments LLC increased its holdings in shares of UnitedHealth Group by 11.8% in the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after acquiring an additional 4,022 shares during the period. Soros Fund Management LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $39,413,000. Finally, Seilern Investment Management Ltd bought a new position in UnitedHealth Group in the fourth quarter worth about $153,015,000. 87.86% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, CFO John F. Rex acquired 17,175 shares of the firm’s stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by company insiders.
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on UNH shares. HSBC reaffirmed a “hold” rating and issued a $490.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, April 22nd. KeyCorp reduced their price target on UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating on the stock in a research report on Wednesday. Wells Fargo & Company dropped their target price on UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating on the stock in a research note on Wednesday. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a report on Thursday. Finally, Barclays cut their price objective on shares of UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating on the stock in a report on Thursday. Six analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $486.00.
View Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is the MACD Indicator and How to Use it in Your Trading
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- The Basics of Support and Resistance
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- 3 Stocks to Consider Buying in October
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.